StonvexLoading…
StonvexStonvexStonvexCore line items from ARDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.68B | $1.60B | $6.32B | $4.72B | $3.14B |
Operating Income | Not available | $74.59M | $286.36M | $193.99M | $196.19M |
Net Income | Not available | $39.85M | $135.81M | $90.86M | $72.95M |
EPS (Diluted) | $0.26 | $0.28 | $0.96 | $0.64 | $0.81 |
Total Assets | Not available | $5.25B | $5.29B | $5.15B | $5.03B |
Total Liabilities | Not available | $3.52B | $3.61B | $3.52B | $3.38B |
Cash & Equivalents | Not available | $609.69M | $709.60M | $609.44M | $540.63M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 143.13M | 142.86M | 143.17M | 143.10M |